[Use of thymalin in the complex treatment of infantile cerebral palsy].
The immunomodulator thymalin was included in the complex of rehabilitative therapy of 22 children with cerebral paralysis expressed in the form of spastic diplegia and with frequent intercurrent infections. Immunological parameters were measured before and after treatment to determine the efficiency of the therapy. Improvement in the neurological defect was observed in 54.55% of children with an impaired function of the immunocompetent system one month after the treatment.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001323:Autoantibodies / Q000032:analysis; D001921:Brain / Q000276:immunology; D002547:Cerebral Palsy / Q000188:drug therapy* / Q000276:immunology; D003131:Combined Modality Therapy; D006801:Humans; D007223:Infant; D007958:Leukocyte Count; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D001323:Autoantibodies; D013951:Thymus Hormones; C032805:thymalin
Primenenie timalina v kompleksnom lechenii detskogo tserebral'nogo paralicha.